Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

Alnylam Pharmaceuticals Inc. (ALNY)

Index:

Nasdaq Composite

Add To Portfolio

$ 339.11

Change Today:

$1.05
52 Week High: $482.13
52 Week Low: $222.98

Currency: US Dollars
Shares Issued: 106.30m
Volume: 2

Market Cap: $36,049m
RiskGrade: 247

Select chart: 1 week | 1 month | 3 month | 6 month | 1 year

Current

1 week

Forecasts

Year Ending	Revenue ($m)	Pre-tax ($m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-26	5,424.13	1,104.77	564.34¢	60.1	0.3	+180%	n/a	0.0%
31-Dec-27	6,956.65	1,990.18	1,075.18¢	31.5	0.3	+90%	n/a	0.0%

Forecast Ratios

Year Ending	Revenue/Share	Price/Revenue per Share
31-Dec-26	$51.02	6.65
31-Dec-27	$65.44	5.18

Trends & Recommendations

	Current	1 week ago	1 month ago	3 months ago	6 months ago	1 year ago
Revenue ($m)
31-Dec-2026	5,424	n/a	n/a	5,051	3,792	3,525
31-Dec-2027	6,957	n/a	n/a	6,376	4,806	n/a

Earnings
31-Dec-2026	564.34¢	n/a	n/a	508.24¢	90.88¢	240.00¢
31-Dec-2027	1075.18¢	n/a	n/a	1003.41¢	488.20¢	n/a

Dividend
31-Dec-2026	n/a	n/a	n/a	n/a	n/a	n/a
31-Dec-2027	n/a	n/a	n/a	n/a	n/a	n/a

Recommendations
Strong Buy	8	8	8	8	8	9
Buy	13	13	13	12	15	11
Neutral	7	7	7	8	8	9
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	1	0
No. of Brokers	28	28	28	28	32	29

Average Rec	7.59	7.59	7.59	7.50	7.27	7.50

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

ALNY Market Data

Currency	US Dollars
Share Price	$ 339.11
Change Today	$ 1.05
% Change	0.31 %
52 Week High	$482.13
52 Week Low	$222.98
Volume	2
Shares Issued	106.30m
Market Cap	$36,049m
RiskGrade	247